RxSight, Inc. to Present at the Piper Sandler Healthcare Conference

Rhea-AI Summary

RxSight (NASDAQ: RXST) will present at the Piper Sandler 37th Annual Healthcare Conference in New York City.

Management is scheduled to present on Wednesday, December 3, 2025 at 12:00 p.m. ET. A live and archived webcast will be available at the company's investor site.

News Market Reaction – RXST

+13.41%

44 alerts

+13.41% Session close to close

+4.1% Peak Tracked

-6.3% Trough Tracked

$427.61M Market Cap

0.7x Rel. Volume

In the Nov 21 session, RXST gained 13.41%, reflecting a significant positive market reaction. Argus tracked a peak move of +4.1% during that session. Argus tracked a trough of -6.3% from its starting point during tracking. Our momentum scanner triggered 44 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Piper Sandler 37^th Annual Healthcare Conference in New York City.

RxSight’s management is scheduled to present on Wednesday, December 3, 2025, at 12:00 p.m. Eastern Time. A live and archived webcast of the presentation will be available at: https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight^® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens^® (LAL^®/LAL+^®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com

FAQ

When will RxSight (RXST) present at the Piper Sandler Healthcare Conference?

RxSight will present on December 3, 2025 at 12:00 p.m. Eastern Time.

How can investors watch the RxSight (RXST) presentation on December 3, 2025?

Investors can view a live webcast and later access an archived webcast at https://investors.rxsight.com/.

What is the ticker symbol for RxSight and where is it listed?

RxSight trades under the ticker RXST on Nasdaq.

What topics will RxSight (RXST) management cover at the Piper Sandler conference?

The company said management will present recent developments and business outlook; the webcast will provide the presentation details.